![]() |
|
| |
Practice Updates for Midwives
- Guidelines & Research on the Prevention of Perinatal Group B Streptococcal Disease
- RCOG/RCM statement on umbilical cord blood collection and banking
- New Cervical Cancer Screening Recommendations (March 2012) from the USPSTF & the ACS
- ACOG Committee Opinions
- 2012 AAP Endorsement of Health and Human Services Recommendation for Pulse Oximetry Screening for Critical Congenital Heart Disease
- Doctors Opposing Circumcision Response to New AAP Statement on Circumcision
- Flu Vaccine in Pregnancy: Recommendations and Resources
- Whooping Cough Reaching Epidemic Levels: Avoid Putting your Clients at Risk
- 2011 Clinical Update: Gestational Diabetes Testing and Management
- Air versus oxygen for resuscitation of infants at birth
- Special Report—Neonatal Resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
- Cord Blood Banking Research and Resources to Inform Shared Decision-Making Discussions with Clients
- Newborn Hearing Screening
- Substance Abuse Screening in Pregnancy
- Managing Hepatitis B positive mothers and out of hospital birth
- Charting Presentation by Karen Hays
RCOG/RCM statement on umbilical cord blood collection and banking
(Joint Statement between UK Royal College of Midwives and Royal College of Obstetricians and Gynaecologists) August 2011. To read statement click here (PDF)
New Cervical Cancer Screening Recommendations (March 2012) from the USPSTF & the ACS
In March 2012, the U.S. Preventive Services Task Force (USPSTF) and the American Cancer Society (ACS) released final versions of their new recommendations on screening for cervical cancer. Although there were some differences in the draft recommendations of these two organizations, final guidelines are in agreement on these points:
- Women should begin cervical cancer screening at age 21.
- Women of average risk between the ages of 21 and 65 should have a Pap smear every 3 years or, for women 30 to 65, a Pap test and an HPV test every 5 years.
- Women over the age of 65 should discontinue screening if prior regular screenings have been normal and they are not at high risk for cervical cancer.
For the ACS, this represents a change from their previous recommendation that women be screened for cervical cancer with an annual Pap smear. Both organizations highlight in their recommendations that HPV testing should not be performed alone (without a Pap smear) and not in women under age 30 unless, the ACS states, a woman has an abnormal Pap test result. READ MORE
For another reference on this topic, consider the ASCCP Guidelines:
The 2006 Consensus Guidelines for the Management of Women with Abnormal Cervical Cancer Screening Tests were published in the American Journal of Obstetrics and Gynecology (2007;197(4):346-355). To read the guidelines as published in AJOG, click here (PDF).
ACOG (American Congress of Obstetricians and Gynecologists) Committee Opinions
- 559 Cesarean Delivery on Maternal Request (April 2013)
- 558 Integrating Immunizations Into Practice (April 2013)
- 557 Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women (April 2013)
- 554 Reproductive and Sexual Coercion (February 2013)
- 552 Benefits to Women of Medicaid Expansion Through the Affordable Care Act (January 2013)
For a complete list of ACOG Committee Opinions, click here
2012 AAP Endorsement of Health and Human Services Recommendation for Pulse Oximetry Screening for Critical Congenital Heart Disease
In January 2012, the Ameican Academy of Pediatrics (AAP) Journal Pediatrics published a Policy Statement announcing their Endorsement of Health and Human Services Recommendation for Pulse Oximetry Screening for Critical Congenital Heart Disease. An earlier article in Pediatrics in Nov 2011 reports on Strategies for Implementing Screening for Critical Congenital Heart Disease. For more information from the CDC about Screening for Critical Congenital Heart Defects, click here.
- CDC Fact Sheet on Screening for Critical Congenital Heart Defects (PDF)
- CDC Web Resources on Screening for Critical Congenital Heart Defects including when to screen
- AAP Endorsement of HHS Recommendation for Pulse Oximetry Screening for Critical Congenital Heart Disease
- AAP Strategies for Implementing Screening for Critical Congenital Heart Disease
Doctors Opposing Circumcision Response to New AAP Statement on Circumcision
"It is clear that the members of the [AAP] task force were chosen with a view to obtaining an outcome favorable for the continued practice of circumcision of male children and to provide for third-party payment to doctors.'The task force was augmented by representatives from the American College of Obstetricians and Gynecologists, and one the American Academy of Family Physicians, representing the two trade associations, other than the AAP, which profit most from performing medically unnecessary non-therapeutic circumcisions on children. Those trade associations are called 'stakeholders'(p. 585 and p. e756). Stakeholders are people with a financial interest in an enterprise. When all charges are considered, medically unnecessary, non-therapeutic circumcision produces more than $1.25 billion in income annually for the stakeholders.
It appears that no member of the task force had a foreskin.
The task force asserts that current evidence that the health benefits of male circumcision
outweigh the risks, but has failed to produce any sort of analysis to support that conclusion.
Previously available cost-benefit studies do not support that conclusion.
READ MORE
New AAP statement on Newborn Male Circumcision (Aug 2012)
Flu Vaccine in Pregnancy: Recommendations and Resources
Many pregnant clients have quite a few questions about the flu vaccine especially during flu season and probably also because the 9a combination shot that provides protection against H1N1 and seasonal flu is also available this 2012-2013 season.
Whether to vaccinate during pregnancy can be a tough decision to make. And, some employers, particularly in the health professions, are strict about their employees getting vaccinated for flu.
Here are some resources for midwives and their clients:
- What’s a Pregnant Mom to Do? Flu Vaccine in Pregnancy by Dr. Aviva Romm.
Two page handout adapted from Dr. Aviva's article (PDF) - CDC Perspective on the Flu Vaccine in Pregnancy
- WA state Department of Health's Information about the Flu Vaccine
- Suspension of WA State Mercury Limits on Certain Flu Vaccine for Pregnant Women
Whooping Cough Reaching Epidemic Levels: Avoid Putting your Clients at Risk
Click below for more information about:
- One Washington Midwife’s Battle with Pertussis
- The DOH’s Recommendations for Pregnant Women and Licensed Midwives regarding Pertussis (pdf)
- DOH Warning that “Whooping cough cases reach epidemic levels in much of Washington"
- Whooping Cough (Pertussis) Fact Sheet
- Seattle Children's Hospital Recommendations and Tools for Cocooning a Newborn
- Center for Disease Control (CDC) 2008 Recommendations for the Prevention of Pertussis indicated that "Available evidence does not address the safety of Tdap for pregnant women, their fetuses, or pregnancy outcomes sufficiently. Available data also do not indicate whether Tdap-induced transplacental maternal antibodies provide early protection against pertussis to infants or interfere with an infant's immune responses to routinely administered pediatric vaccines."
- CDC's Updated 2011 Recommendations for Use of Tdap in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months indicate that the "ACIP concluded that available data from these studies did not suggest any elevated frequency or unusual patterns of adverse events in pregnant women who received Tdap and that the few serious adverse events reported were unlikely to have been caused by the vaccine."
- 2011 CDC Pertussis Information
The Department of Health recommends the Tdap booster vaccine "for everyone who will have contact with new infants, especially pregnant women, family members, and health care workers."
Vaccine Information: The WA state Department of Health reports that a pertussis-only vaccine is not available. Pertussis is included in the TDap adult vaccine which is considered a lifetime booster and does not contain thimeresol. Licensed Midwives cannot administer the vaccine but are encouraged to advise clients to request the vaccine from their PCP or to have them call their local pharmacy and inquire about receiving it there. The DOH does not currently have vaccine clinics.
2011 Clinical Update: Gestational Diabetes Testing and Management
A summary of the most recent research and Guidelines on Gestational Diabetes compiled by MAWS member Kristin Effland, LM, CPM. This compilation of data was originally presented at the 2010 MANA (Midwives Alliance of North America) Conference but was also updated in September 2011.
Click here for this 2011 Clinical Update on GDM Testing and Management.
Newborn Hearing Screening
Why screen for hearing loss? Only approximately 50% of hearing loss in children is traceable to risk factors such as family history of hearing loss, illness during pregnancy or birth complications. By not screening we miss 50% of all hearing impaired children.
Click here for a full discussion from the Washington DOH and a handout that can be shared with parents.
Substance Abuse Screening in Pregnancy
Substance abuse during pregnancy has been identified as an issue critical to the health of mothers and babies from all socioeconomic groups. It is estimated that in Washington State, between 8,000 and 10,000 infants born each year are exposed prenatally to illegal drugs or alcohol.
Click here for the revised screening guidelines document from the WA DOH. (PDF)
Managing Hepatitis B positive mothers and out of hospital birth
Hepatitis B virus (HBV) infection in a pregnant woman poses a serious risk to her infant at birth. Without postexposure immunoprophylaxis, approximately 40% of infants born to HBV-infected mothers in the United States will develop chronic HBV infection. Of that 40%, approximately one-fourth will eventually die from chronic liver disease or liver cancer.
Click here for a full discussion of the subject and additional resources.
Charting Presentation by Karen Hays
In 2011, Karen Hays, CNM, PhD presented at the MAWS Spring Conference on the topic of Charting for Midwives. She focuses on the differences between charting as a nurse vs. charting as an autonomous care provider. She provides specific examples and makes recommendations for improving the chart forms that many MAWS members use that were developed by MAWS several years ago. Her presentation is here in two documents:
Charting Presentation (PDF)
Charting Examples (PDF)
Air versus oxygen for resuscitation of infants at birth
About 5 to 10% of infants need resuscitation at birth. Many experts recommend that these babies be resuscitated with 100% oxygen, but other experts think that normal room air is as good as or better than 100% oxygen. Too much oxygen can make breathing difficult for babies and can cause other problems such as problems with brain development, an eye condition (retinopathy of prematurity), and a lung condition (bronchopulmonary dysplasia). The authors of this Cochrane review questioned whether resuscitation with room air resulted in fewer deaths or disabilities than 100% oxygen. After searching the literature, they found five studies. There were a total of 1302 infants in these studies; 24% of them were premature. In the studies, fewer babies died when resuscitated with room air than with 100% oxygen. Many of the babies resuscitated with room air also got some oxygen as a supplement, making it difficult to compare the two groups. There were also other problems with the way the studies were carried out. The authors of the Cochrane review concluded that there is not enough evidence to recommend room air over 100% oxygen, or vice versa.
Special Report—Neonatal Resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
This special report was published in Pediatrics Volume 126, Number 5, November 19, 2010. They write that the "guidelines are an interpretation of the evidence presented
in the 2010 International Consensus on Cardiopulmonary Resuscitation
and Emergency Cardiovascular Care Science With Treatment
Recommendations1). They apply primarily to newly born infants undergoing
transition from intrauterine to extrauterine life, but the recommendations
are also applicable to neonates who have completed perinatal
transition and require resuscitation during the first few weeks to
months following birth. Practitioners who resuscitate infants at birth
or at any time during the initial hospital admission should consider
following these guidelines. For the purposes of these guidelines, the
terms newborn and neonate are intended to apply to any infant during
the initial hospitalization. The term newly born is intended to apply
specifically to an infant at the time of birth.
Approximately 10% of newborns require some assistance to begin
breathing at birth. Less than 1% require extensive resuscitative measures."
Full article available through HEAL-WA to LMs and other WA Health Care Providers as an EJOURNAL.
Guidelines & Research on the Prevention of Perinatal Group B Streptococcal Disease
Cochrane Review of the Research on the Prevention of Perinatal Group B Streptococcal Disease (GBS) with Prophylactic Antibiotics (Jan 2013)
Access the full Cochrane Review abstract here.
LMs and CNMs in WA can access the full text Review through Heal-WA.
Revised Guidelines for the Prevention of Perinatal Group B Streptococcal (GBS) Disease were published in the Morbidity and Mortality Weekly Report (MMWR) on November 19, 2010. These 2010 guidelines were developed using an evidence-based approach in collaboration with several professional associations. They received formal endorsements from:
- American Academy of Family Physicians (AAFP)
- American Academy of Pediatrics (AAP)
- American College of Nurse-Midwives (ACNM)
- American College of Obstetricians and Gynecologists (ACOG)
- American Society for Microbiology (ASM)
2010 CDC Guidelines for the Prevention of Perinatal Group B Streptococcal Disease
Hi-lights from the 2010 Revised CDC Guidelines on the Prevention of Perinatal GBS Disease
SOGC Clinical Guidelines (2004) - PDF
Cord Blood Banking Research and Resources to Inform Shared Decision-Making Discussions with Clients
"Immediate or early cord clamping vs delayed clamping." by DJ Hutchon. in the Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2012 Nov;32(8):724-9. doi: 10.3109/01443615.2012.721030. Full Text Article available online and through Heal-WA.
"Rethinking placental transfusion and cord clamping issues." by Mercer JS, & Erickson-Owens DA. in The Journal of Perinatal and Neonatal Nursing. 2012 Jul-Sep;26(3):202-17; quiz 218-9. Article available to LMs and CNMs through Heal-WA.
The Royal College of Midwives (RCM) in the UK is set to issue advice that midwives should wait before cutting the umbilical cord. Read More.
- The current "Evidence Based Guidelines for Midwifery-Led Care in Labour Third Stage of Labour." by the RCM.
- Popular media articles discussing the new recommendations: The Telegraph. Daily Mail Online.
- Swedish Study shows that Delayed Clamping Reduces Iron Deficiency with no evidence for increasing jaundice
Cochrane Review on the Benefits and Risks of Delayed Cord Clamping
Video by Penny Simkin on the Benefits of Delayed Cord Clamping
- FOR MIDWIVES
- Indications for Consultation & Transfer
- Midwifery Position Statements
- Practice Updates
- Clinical Guidelines
- Mechanism for Expanding Clinical Procedures
- Standards for Practice
- Tools for Midwives – Forms & Templates
- Continuing Education Opportunities
- Current Research
- Quality Management Program
- Resources on Disparities, Anti-Racism & Anti-Oppression
- Discussion Forum for Professional Members
RELATED LINKS
International Midwifery Guidelines & Updates on the Evidence
Cochrane Reviews related to Pregnancy and Childbirth
Cochrane Reviews are systematic reviews of primary research in human health care and health policy, and are internationally recognised as the highest standard in evidence-based health care.



